WallStreetZen

NYSE: MRK
Merck & Co Inc Earnings & Revenue

MRK past earnings growth

How has MRK's earnings growth performed historically?
Company
-30.15%
Industry
14.79%
Market
102.72%
MRK's earnings have grown slower (11% per year) than the US Drug Manufacturers - General industry average (14.81%)
Performance
MRK's earnings have grown slower (11% per year) than the US market average (27.52%)
Performance
MRK's earnings growth is slowing down - its growth over the last year (-30.15%) is below its 5-year compound annual rate (11%)
Performance

MRK past revenue growth

How has MRK's revenue growth performed historically?
Company
-0.13%
Industry
13.32%
Market
36.32%
MRK's revenue has grown slower (4.04% per year) than the US Drug Manufacturers - General industry average (5.13%)
Performance
MRK's revenue has grown slower (4.04% per year) than the US market average (17.66%)
Performance
MRK's revenue growth is slowing down - its growth over the last year (-0.13%) is below its 5-year compound annual rate (4.04%)
Performance

MRK earnings and revenue history

Current Revenue
$48.0B
Current Earnings
$7.0B
Current Profit Margin
14.6%
MRK's has demonstrated consistent long-term earnings growth over the past 10 years (434.62%)
Performance

MRK Return on equity

Current Company
25.8%
Current Industry
31.9%
Current Market
30.7%
MRK's Return on Equity (25.8%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

MRK Return on assets

Current Company
7.7%
Current Industry
6.8%
Current Market
6.4%
MRK is generating higher Return on Assets (7.7%) than the US Drug Manufacturers - General industry average (7.27%)
Performance

MRK Return on capital employed

Current Company
13.02%
Current Industry
11.3%
MRK has gotten more efficient at generating Return on Capital (13.02%) compared to 3 years ago (8.45%)
Performance

Merck & Earnings & Revenue FAQ

What were MRK's earnings last quarter?

On Apr 29, 2021, Merck & (NYSE: MRK) reported Q1 2021 earnings per share (EPS) of $1.26, up 0.79% year over year. Total Merck & earnings for the quarter were $3.18 billion. In the same quarter last year, Merck &'s earnings per share (EPS) was $1.27.

What was MRK's earnings growth in the past year?

As of Q3 2021, Merck &'s earnings has grown -30.15% year over year. This is 44.94 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 14.79%. Merck &'s earnings in the past year totalled $7.03 billion.

What was MRK's revenue last quarter?

On Apr 29, 2021, Merck & (NYSE: MRK) reported Q1 2021 revenue of $12.08 billion up 0.19% year over year. In the same quarter last year, Merck &'s revenue was $12.06 billion.

What was MRK's revenue growth in the past year?

As of Q3 2021, Merck &'s revenue has grown -0.13% year over year. This is 13.45 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 13.32%. Merck &'s revenue in the past year totalled $48.02 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.